Torre 2015: Global cancer statistics, 2012
The GLOBOCAN-based world count for 2012: about 14.1 million new cancer cases, with more than half of cases and almost two thirds of deaths occurring in less developed regions, and lung cancer leading in men while breast cancer led in women.
Overview
Torre, Bray, Siegel and colleagues summarised the GLOBOCAN 2012 estimates for the American Cancer Society. They reported about 14.1 million new cases and 8.2 million deaths in 2012, with 57% of cases and 65% of deaths in less developed regions. Lung cancer was the leading cancer in men for both incidence and mortality; breast cancer led in women. The paper highlighted the rising share of the burden in transitioning countries and the potential of prevention, early detection and treatment to reduce it.
- About 14.1 million new cancer cases and 8.2 million cancer deaths worldwide in 2012.
- 57% of cases and 65% of deaths occurred in less developed regions.
- Lung cancer the leading cause of cancer incidence and death in men; breast cancer the leading cancer in women.
One of the most cited descriptions of the global cancer burden of the 2010s, it framed the shift of cancer towards lower-income countries that later GLOBOCAN releases have confirmed.
- Superseded by the 2018, 2020 and 2022 GLOBOCAN releases.
- Estimates for many countries were modelled from limited registry data.
Similar pages
not linked directly; found by shared links- Key paperSung 2021: GLOBOCAN 2020, the year breast cancer overtook lung cancer as the most diagnosed cancer
Shares Freddie Bray, Incidence versus prevalence, Bray 2018: GLOBOCAN 2018, worldwide incidence and mortality for 36 cancers, Mortality.
- Key paperFitzmaurice 2017: the Global Burden of Disease estimate of cancer in 2015
Shares Incidence versus prevalence, Bray 2018: GLOBOCAN 2018, worldwide incidence and mortality for 36 cancers, Mortality, Non-small-cell lung cancer.
- Key paperBray 2024: GLOBOCAN 2022, the world's cancer count for 36 cancers in 185 countries
Shares Freddie Bray, Bray 2018: GLOBOCAN 2018, worldwide incidence and mortality for 36 cancers, International Agency for Research on Cancer (IARC / WHO), HR-positive / HER2-negative breast cancer.
- Key paperChen 2016: Cancer statistics in China, 2015
Shares Incidence versus prevalence, Bray 2018: GLOBOCAN 2018, worldwide incidence and mortality for 36 cancers, Mortality, Non-small-cell lung cancer.
- Key paperAllemani 2018: CONCORD-3, global surveillance of cancer survival 2000 to 2014
Shares Bray 2018: GLOBOCAN 2018, worldwide incidence and mortality for 36 cancers, Mortality, HR-positive / HER2-negative breast cancer, Non-small-cell lung cancer.
- Key paperSiegel 2024: Cancer statistics, 2024, the American Cancer Society's annual US report
Shares Incidence versus prevalence, Mortality, HR-positive / HER2-negative breast cancer.
- TermPrognosis
Shares Incidence versus prevalence, Mortality.
- PersonAndré Ilbawi
Shares International Agency for Research on Cancer (IARC / WHO), HR-positive / HER2-negative breast cancer.